869367-33-9

Basic information

• Product Name: (1E,4E)-8-chloro-4-((diMethylaMino)Methylene)-1-(2-fluoro-6-Methoxyphenyl)-3,4-dihydrobenzo[c]azepin-5-one
• Synonyms: (1E,4E)-8-chloro-4-((diMethylaMino)Methylene)-1-(2-fluoro-6-Methoxyphenyl)-3,4-dihydrobenzo[c]azepin-5-one;8-Chloro-4-[(dimethylamino)methylene]-1-(2-fluoro-6-methoxyphenyl)-3,4-dihydro-5H-2-benzazepin-5-one
• CAS NO: 869367-33-9
• Molecular Formula: C₂₀H₁₈ClFN₂O₂
• Molecular Weight: 372.8205232
• Mol File: 869367-33-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (1E,4E)-8-chloro-4-((diMethylaMino)Methylene)-1-(2-fluoro-6-Methoxyphenyl)-3,4-dihydrobenzo[c]azepin-5-one(CAS DataBase Reference)
• NIST Chemistry Reference: (1E,4E)-8-chloro-4-((diMethylaMino)Methylene)-1-(2-fluoro-6-Methoxyphenyl)-3,4-dihydrobenzo[c]azepin-5-one(869367-33-9)
• EPA Substance Registry System: (1E,4E)-8-chloro-4-((diMethylaMino)Methylene)-1-(2-fluoro-6-Methoxyphenyl)-3,4-dihydrobenzo[c]azepin-5-one(869367-33-9)

Safety Data

• Hazardous Substances Data: 869367-33-9(Hazardous Substances Data)

Usage

Description

(1E,4E)-8-chloro-4-((diMethylaMino)Methylene)-1-(2-fluoro-6-Methoxyphenyl)-3,4-dihydrobenzo[c]azepin-5-one is a synthetic organic compound with a complex molecular structure. It features a chloro group, a dimethylamino group, a methylene group, and a fluoro-6-methoxyphenyl group, all attached to a dihydrobenzo[c]azepin-5-one core. (1E,4E)-8-chloro-4-((diMethylaMino)Methylene)-1-(2-fluoro-6-Methoxyphenyl)-3,4-dihydrobenzo[c]azepin-5-one may have potential pharmaceutical applications, as similar structures have been studied for their potential as antipsychotic and antidepressant drugs. The presence of a chlorine atom in the structure may also confer unique chemical properties, making it of interest for further study in medicinal chemistry and pharmacology.

Uses

Used in Pharmaceutical Industry:
(1E,4E)-8-chloro-4-((diMethylaMino)Methylene)-1-(2-fluoro-6-Methoxyphenyl)-3,4-dihydrobenzo[c]azepin-5-one is used as a potential candidate for the development of antipsychotic and antidepressant drugs due to its structural similarities with compounds that have been investigated for these therapeutic applications. Its unique chemical properties, including the presence of a chlorine atom, may contribute to its effectiveness in treating mental health disorders.

Upstream product

• 869367-01-1 8-chloro-1-(2-fluoro-6-methoxyphenyl)-3,4-dihydrobenzo[c]azepin-5-one 
• 869366-70-1 tert-butyl {3-[4-chloro-2-(2-fluoro-6-methoxybenzoyl)phenyl]prop-2-yn-1-yl}carbamate 
• 869365-89-9 (2-amino-5-chlorophenyl)(2-fluoro-6-methoxyphenyl)methanone 
• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 
• 1233025-91-6 (5-chloro-2-iodophenyl)(2-fluoro-6-methoxyphenyl)methanone 
• 28910-83-0 (2-amino-5-chlorophenyl)-(2,6-difluorophenyl)methanone 
• 869365-97-9 (5-chloro-2-iodophenyl)(2,6-difluorophenyl)methanone 

Downstream Products

• 1028486-01-2 alisertib 
• 1028486-06-7 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoate sodium salt 

Relevant articles and documents

Small molecule with Aurora kinase degradation activity, preparation method and application thereof

The invention discloses a small molecule with Aurora kinase degradation activity, a preparation method and application thereof. According to the invention, 12 Aurora-A protein degradation agents basedon a PROTAC technology are obtained by using three E3 u

CRYSTALLINE FORMS OF SODIUM 4-{[9-CHLORO-7-(2-FLUORO-6--METHOXYPHENYL)-5H -PYRIMIDO[5,4-D][2]BENZAZEPIN-2YL]AMINO}-2-METHOXYBENZOATE

The present invention is directed to a compound of formula (Z): or a crystalline form thereof, or a solvate thereof; to a solid pharmaceutical composition comprising a pharmaceutically effective amount of the compound of formula (I), or a crystalline form